Kinnos was founded to protect our healthcare workers and patients. During our junior year of college in October 2014, we joined Columbia's Ebola Design Challenge to help fight the Ebola crisis in West Africa, and so the first prototype of Highlight® was born. Since then, we've recognized the urgent need to improve decontamination for both epidemic response and daily disinfection and the tangible impact Highlight® can have around the world. Our goal is to empower healthcare workers and patients to protect themselves and others, eliminate human error during decontamination, and prevent the unnecessary loss of life.
Learn more about our journey and progress on our blog.
Jason Kang studied Biomedical Engineering at Columbia University as an Egleston Scholar and graduated Tau Beta Pi. Jason has previously conducted research at Harvard Medical School and Columbia University, interned at Transcriptic, and served as the VP of Engineering at Jibon Health Technologies, where he brought a medical device to clinical trials in Bangladesh. Jason has served as a U.S. Delegate at the Global Entrepreneurship Summit and is a Kairos Fellow.
Katherine Jin double-majored in Biology and Computer Science as a Coca-Cola Scholar at Columbia University. Katherine has worked in the Trauma Center and as a clinical researcher at Mount Sinai St. Luke's Hospital, and has conducted research at the Carnegie Institute of Washington and Columbia University. While at Columbia, Katherine served as Campus Coordinator of the Harlem Hospital Chapter of Health Leads.
Kevin Tyan graduated from Columbia University with Honors in Biology. Kevin has extensive experience in virology and immunology and has conducted research at the National Institutes of Health, MedImmune-AstraZeneca, and Columbia University Medical Center. He previously led Columbia University's Emergency Medical Service and has worked directly with first responders.
NAHID BHADELIA, MD, MA
National Emerging Infectious Diseases Laboratory
Assistant Professor of Medicine - Section of Infectious Diseases
Boston University School of Medicine
ELIAS SHAHEEN, PHD, MBA
Retired Research Director
The Clorox Company
JOHN DEFORD, PHD
Senior Vice President of Science, Technology and Clinical Affairs